Vestal Point Capital, LP
CIK: 0001974915Latest portfolio: $2.9B · Q4 2025
Holdings
76
Total Value
$2.9B
New Positions
24
Closed Positions
29
Top Holdings
View All 76 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ABVXAbivax SA | 1,900,000 | $256.2M | 8.71% | +900K | |
| 2 | NDQInvesco QQQ Trust Series 1 | 350,000 | $215.0M | 7.31% | NEW | Put |
| 3 | ACLXArcellx Inc | 2,925,000 | $190.7M | 6.48% | +1.7M | |
| 4 | TERNTerns Pharmaceuticals Inc | 4,500,000 | $181.8M | 6.18% | NEW | |
| 5 | BMRNBioMarin Pharmaceutical Inc | 3,000,000 | $178.3M | 6.06% | +2.2M | |
| 6 | GMEDGlobus Medical Inc | 1,275,000 | $111.3M | 3.78% | +25K | |
| 7 | NRIXNurix Therapeutics Inc | 4,690,000 | $89.0M | 3.02% | +1.2M | |
| 8 | ALCAlcon AG | 1,105,000 | $87.1M | 2.96% | +5K | |
| 9 | DC4Dexcom Inc | 1,275,000 | $84.6M | 2.88% | +625K | |
| 10 | MRKMerck & Co Inc | 775,000 | $81.6M | 2.77% | NEW | |
| 11 | TSHATaysha Gene Therapies Inc | 13,750,000 | $75.6M | 2.57% | +8.3M | |
| 12 | ABTAbbott Laboratories | 600,000 | $75.2M | 2.56% | +350K | |
| 13 | IMTXImmatics NV | 6,125,000 | $64.3M | 2.19% | -225,000 | |
| 14 | TYRATyra Biosciences Inc | 2,425,000 | $63.8M | 2.17% | — | |
| 15 | BCAXBicara Therapeutics Inc | 3,575,000 | $60.2M | 2.05% | -1,525,000 | |
| 16 | ARWRArrowhead Pharmaceuticals Inc | 900,000 | $59.8M | 2.03% | NEW | |
| 17 | ELVNEnliven Therapeutics Inc | 3,830,000 | $59.0M | 2.01% | +2.7M | |
| 18 | IRONDisc Medicine Inc | 735,000 | $58.4M | 1.98% | +235K | |
| 19 | JAZZJazz Pharmaceuticals PLC | 290,000 | $49.3M | 1.68% | -210,000 | |
| 20 | DAWNDay One Biopharmaceuticals Inc | 5,200,000 | $48.5M | 1.65% | +2.5M | |
| 21 | LXEOLexeo Therapeutics Inc | 4,475,000 | $44.4M | 1.51% | +1.2M | |
| 22 | ANROAlto Neuroscience Inc | 2,485,000 | $44.2M | 1.50% | +1.5M | |
| 23 | APGEApogee Therapeutics Inc | 550,000 | $41.5M | 1.41% | +125K | |
| 24 | OLMAOlema Pharmaceuticals Inc | 1,650,000 | $41.3M | 1.40% | NEW | |
| 25 | AXSMAxsome Therapeutics Inc | 210,000 | $38.4M | 1.30% | +60K |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Unknown0.0% ($21500884621316411392.0T)
Filing History
Fund Information
Vestal Point Capital, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $2.9B across 76 holdings. The largest position is Abivax SA (ABVX), representing 8.7% of the portfolio. Compared to the previous quarter, the fund opened 25 new positions and closed 30 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.